Fred Hutch is an internationally recognized organization dedicated to advancing discoveries and developing novel therapeutics for cancer, immunodeficiencies, infectious diseases and in conducting research aimed at improving quality of life for cancer survivors. Fred Hutch investigators are pioneers in stem cell transplantation and Immunotherapy. As the home of three Nobel Laureates, and the birthplace of bone marrow transplantation, Fred Hutch is now leading the field in developing novel immunotherapies including chimeric antigen receptor T cells (CAR T), T cell receptor therapies (TCRs), protein therapeutics (Bispecific antibodies, cystine-dense peptides) and advancing new approaches in stem cell transplantation in children and adults.
Faculty in Pediatric Oncology program are fully integrated into the clinical and research infrastructure of Fred Hutch and together they are committed to advancing therapeutics for treatment of life-threatening conditions in infants, children, adolescents and young adults. Each member of the Fred Hutch Pediatric Oncology program is an internationally acclaimed investigators as clinical or laboratory based scientists, and are dedicated to advancing science and finding cures for pediatric patients.